Ten years experience of managing the primary tumours in patients with stage IV colorectal cancers

被引:50
作者
Aslam, Muhammad Imran [1 ]
Kelkar, Ashish [1 ]
Sharpe, David [1 ]
Jameson, John Stuart [1 ]
机构
[1] Univ Hosp Leicester NHS Trust, Leicester Gen Hosp NHS Trust, Dept Colorectal Surg, Leicester, Leics, England
关键词
Stage IV; Advanced; Colorectal cancers; Survival; Resection of primary tumour; EXPANDING METAL STENTS; HUMAN COLON-CANCER; LIVER METASTASES; NONOPERATIVE MANAGEMENT; SYNCHRONOUS METASTASES; OVARIAN-CANCER; GROWTH-FACTOR; RESECTION; CHEMOTHERAPY; CARCINOMA;
D O I
10.1016/j.ijsu.2010.03.005
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: Approximately 20% of patients with colorectal cancer have metastases at the time of presentation. Such patients are often offered systemic chemotherapy but debate continues as to whether these patients benefit from resection of the primary tumour. We describe our ten years experience of managing the primary tumours in patients with stage IV colorectal cancer. The aim of this study was to describe the overall survival of patients undergoing surgery in these circumstances and to determine whether any prognostic indicators could be identified. Patients & methods: 920 consecutive patients presenting with stage IV colorectal cancer disease were identified from the Leicester Colorectal Cancer database. Patients undergoing resection of the primary tumour (Resection Group) with the residual metastatic disease were compared to those patients who had not their primary tumour excised (Non-Resection Group). Various different variables in two groups were compared by using Mann-Whitney U test. Kaplan-Meier survival analysis and log-rank test were used to compare the overall survivals. Univariate analysis was performed for each group to elicit the significant prognostic factors whereas Cox regression model was used to identify the independent predictors of overall survival. Results: The Kaplan-Meier survival analysis of two groups showed prolonged survival for Resection Group compared to the Non-Resection Group (median; 14.5 Vs 5.83 months, p = <0.005). The multivariate analysis of different survival predicting variables, revealed the resection of the primary tumour as an independent predictor of overall survival (p < 0.001). The univariate analysis of resection group identified age at presentation, tumour site, tumour stage (pT), lymph nodal stage (pN), complete histological resection, tumour fixity, ASA grade, mode of surgery, post-operative chemotherapy and sites of metastasis as significant factors (p < 0.05) for survival prediction. When these factors were used in Cox-Regression model, only the age at presentation (p = 0.001), tumour fixity (p = 0.012) and lymph nodal involvement (p = 0.042) were independent predictors for overall survival. Treatment with postoperative chemotherapy and a smaller volume of liver metastases were associated with prolonged survival (p < 0.05). Conclusions: Surgical resection of primary tumour for stage IV colorectal cancers is associated with prolonged survival for selected patients. Age at presentation, extent of liver involvement, tumour fixity and ASA grade can help to decide the patients who will benefit from surgery. (C) 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:305 / 313
页数:9
相关论文
共 40 条
[1]  
ALASFOOR A, 2009, COCHRANE DB SYST REV, V2
[2]  
[Anonymous], 2008, Cancer facts and figures
[3]  
BACON HE, 1964, DIS COLON RECTUM, V36, P211
[4]   Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases [J].
Benoist, S ;
Pautrat, K ;
Mitry, E ;
Rougier, P ;
Penna, C ;
Nordlinger, B .
BRITISH JOURNAL OF SURGERY, 2005, 92 (09) :1155-1160
[5]  
*CANC RES UK, 2009, UK BOW CANC MORT STA
[6]   Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: An analysis of surveillance, epidemiology, and end results data, 1988 to 2000 [J].
Cook, AD ;
Single, R ;
McCahill, LE .
ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (08) :637-645
[7]   Critique of surgical cytoreduction in advanced ovarian cancer [J].
Covens, AL .
GYNECOLOGIC ONCOLOGY, 2000, 78 (03) :269-274
[8]   Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer [J].
Flanigan, RC ;
Salmon, SE ;
Blumenstein, BA ;
Bearman, SI ;
Roy, V ;
McGrath, PC ;
Caton, JR ;
Munshi, N ;
Crawford, ED .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1655-1659
[9]   Guidelines for resection of colorectal cancer liver metastases [J].
Garden, O. J. ;
Rees, M. ;
Poston, G. J. ;
Mirza, D. ;
Saunders, M. ;
Ledermann, J. ;
Primrose, J. N. ;
Parks, R. W. .
GUT, 2006, 55 :1-8
[10]   PROLIFERATION OF HUMAN COLON CANCER-CELLS - ROLE OF EPIDERMAL GROWTH-FACTOR AND TRANSFORMING GROWTH-FACTOR-ALPHA [J].
HUANG, S ;
TRUJILLO, JM ;
CHAKRABARTY, S .
INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (06) :978-986